“3D MOLECULAR DOCKING COMBINED WITH AI-DRIVEN VIRTUAL SCREENING TO REPURPOSE FDA-APPROVED DRUGS FOR RARE NEURODEGENERATIVE DISEASES”. 2024. International Journal of Experimental Biology 2 (01): 50-73. https://ijeb.online/index.php/IJEB/article/view/23.